Helping developing countries fight malaria – QIMR’s Infectious Disease Research Program
(If you're not yet a fan, join us now by clicking the Like button)
Introduction by Professor Marc Van Ranst, Chairman of the editorial board VNN
-
This site complies with the HONcode standard for trustworthy health information: verify here. 
Latest Post
- How are vaccines developed?
- Vaxart’s Tablet Vaccine for H1N1 Influenza Generates Protective Immunity Equivalent to Injectable in Phase I Clinical Study
- First moments for Pampers/UNICEF: “one pack = one life saving vaccine”
- Russian HIV vaccine heading for phase II trials
- HPV Vaccine does not cause multiple sclerosis
Follow us on Twitter
Follow @VacciNewsNet
Join us on Facebook
QIMR researchers are looking for ways to control and prevent malaria, by attacking either the parasite that causes the disease or the mosquito that spreads it.
Researchers at the Queensland Institute of Medical Research have developed a method to conduct clinical trials to test new antimalarial drugs. We are currently trialling new treatments and therapies to stop the Plasmodium (malaria) parasite from causing disease.
We are also working towards a vaccine against malaria. If a malaria vaccine can be developed, this will stop the burden of this disease in countries like Africa, where a child dies every minute from malaria.